BMO Global Health Care Active ETF SeriesCBOE Canada:BGHC
No Matches were found for
- LAST PRICE17.29
- TODAY'S CHANGE (%)-0.01 (-0.06%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.00 / 17.30
- Day Range---
- 52 Week Range
- Volume---
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BGHC |
|---|---|---|
| 03:59 ET | 0 | 17.29 |
Asset Class
| US Equity | 73.6% |
|---|---|
| Int'l Equity | 25.5% |
| Cash | 0.9% |
| CDN Equity | 0 |
| Fixed Income | 0 |
| Other | 0 |
Sectors
| Healthcare | 97.6% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
Geographic Region
| United States | 75.4% |
|---|---|
| Asia/Oceania | 1.4% |
| Europe | 1.4% |
| Africa | 0 |
| Latin America | 0 |
| Canada | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 8.8% | +3,827.65% | $16.0M |
Novo Nordisk A/S Class B | Long | 8.3% | +3,835.29% | $15.1M |
UnitedHealth Group Inc | Long | 7.7% | +3,827.61% | $14.1M |
Merck & Co Inc | Long | 5.3% | +4,800.09% | $9.6M |
Thermo Fisher Scientific Inc | Long | 5.0% | +3,080.11% | $9.1M |
AbbVie Inc | Long | 4.9% | +3,836.83% | $9.0M |
AstraZeneca PLC | Long | 4.5% | +3,850.48% | $8.2M |
Boston Scientific Corp | Long | 3.7% | +3,839.11% | $6.7M |
Intuitive Surgical Inc | Long | 3.6% | +3,823.62% | $6.6M |
Elevance Health Inc | Long | 3.6% | +3,828.51% | $6.5M |
Reports
No reports available
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | BMO Asset Management Inc |
Inception | June 29, 2023 |
This fund’s objective is to increase the value of your investment over the long term by investing primarily in companies that operate in, or are expected to benefit from, health care related businesses from around the world.
| Total Net Assets | $117.5M |
|---|---|
| Shares Out. | 6.7M |
| Net Asset Value (NAV) | $17.23 |
| Prem/Discount to NAV | 0.15% |
| P/E Ratio | 35.3 |
| Dividend Yield | --- |
| Dividend per Share | --- |
| Ex-Dividend Date | --- |
| Dividend Payment Date | --- |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Large Cap Growth |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.90% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.98% |